Skip to content

PROSE: Prospective Randomized On-X / St. Jude Medical Evaluation

PROSE: Prospective Randomized On-X / St. Jude Medical Evaluation - PROSE study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39125
Enrollment
30
Registered
2009-07-14
Start date
2009-09-29
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bloodclot complications incidence of obstruction due to bloodclot.

Interventions

Haert Valve replacement of the Mitral valve or Aortic valve with a mechanical heart valve prothesis.

Sponsors

On-X Life Technologies, Inc
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Isolated mitral - or isolated aortic valve replacement (eligible for coronary artery bypass and / or concomitant repair of mitral of tricuspid valves) 2. Candidate for receipt of mechanical heart valve

Exclusion criteria

Exclusion criteria: Patient is not a candidate to receive a mechanical heart valve Double valve replacement Patient requires tricuspid valve replacement Enrollment in another investigative trial / study

Design outcomes

Primary

MeasureTime frame
Incidence of major thromboembolic events during 5 year FU

Secondary

MeasureTime frame
_

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)